This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Lattice Biologics (LBL) Stock Overview

A biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. More details

LBL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

LBL Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Lattice Biologics Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Lattice Biologics
Historical stock prices
Current Share PriceUS$0.04
52 Week HighUS$0.04
52 Week LowUS$0.04
Beta0
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Change100.00%
Change since IPO-88.24%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

LBLCA BiotechsCA Market
7Dn/a0.4%0.6%
1Yn/a5.1%19.3%

Return vs Industry: Insufficient data to determine how LBL performed against the Canadian Biotechs industry.

Return vs Market: Insufficient data to determine how LBL performed against the Canadian Market.

Price Volatility

Is LBL's price volatile compared to industry and market?
LBL volatility
LBL Average Weekly Movementn/a
Biotechs Industry Average Movement10.1%
Market Average Movement9.2%
10% most volatile stocks in CA Market18.2%
10% least volatile stocks in CA Market3.6%

Stable Share Price: LBL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine LBL's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aGuy Cookn/a

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration The company also develops amniotic fluid-based products, such as AmnioBoost and AmnioBlast. In addition, it sells traditional allografts for multi-disciplinary applications, including orthopedics, neurology, podiatry, and oral/maxillofacial.

Lattice Biologics Ltd. Fundamentals Summary

How do Lattice Biologics's earnings and revenue compare to its market cap?
LBL fundamental statistics
Market capCA$175.12
Earnings (TTM)-CA$1.30m
Revenue (TTM)CA$2.13m
0.0x
P/S Ratio
0.0x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LBL income statement (TTM)
RevenueUS$1.56m
Cost of RevenueUS$912.36k
Gross ProfitUS$645.64k
Other ExpensesUS$1.60m
Earnings-US$951.65k

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did LBL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/16 12:46
End of Day Share Price 2024/07/15 00:00
Earnings2021/06/30
Annual Earnings2020/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lattice Biologics Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siddharth RajeevFundamental Research Corp.